Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2353

Nov 10, 2017

Natural Killer Cells Swarm to Attack Cancer Thanks to New Immunotherapy

Posted by in category: biotech/medical

Natural killer (NK) cells are lymphocytes, immune cells which have a powerful arsenal of cytotoxic weaponry that they can use against tumors.

Unfortunately, tumors protect themselves using a protective microenvironment that shields them from attack from NK cells. This microenvironment promotes tumor growth and survival and has an immunosuppressive effect that blunts the attempts of NK cells to infiltrate the tumor and destroy it. That was until now and this new discovery.

Read more

Nov 8, 2017

Liz Parrish in keynote interview at The Business of Longevity Conference in Hong Kong

Posted by in categories: biotech/medical, business, life extension

Our CEO, Liz Parrish was invited at this event for a keynote interview with Charles Goddard, the editorial director for The Economist Asia Pacific Intelligence Unit. They discussed the complexity of regulations, the extraordinarily long time it takes for drug development from bench to bedside, the current funding environment surrounding biotech, and the pace of medical innovations. During the keynote, Liz emphasized that BioViva’s main aim is to make advanced gene and cell therapies available to all patients in need. To further this cause BioViva supports innovative and adaptive clinical trials, new models for preclinical testing, and accelerating the time to develop advanced gene and cell therapy. Finally, Liz highlighted the importance of testing gene and cell therapy in humans as quickly as possible, because animal models are not accurate.

Read more

Nov 8, 2017

Increased Risk of Breast Cancer Due to Contraceptive Pills

Posted by in categories: biotech/medical, health

Progesterone and Oestrogen are produced by the ovaries and the amount of their production varies naturally, after the menstrual cycle. The birth-control replaces these naturally produced hormones with the synthetic versions.

Strassmann states that there is a direct connection between the contraceptive pills and the risk of breast cancer. She extracted data from 12 various studies which measure the amount of oestrogen and progesterone over the menstrual cycle in women who do not take these pills. The study is a continuation of her previous research on menstruation and reproductive biology among the Dogon people of Mali in Western Africa.

According to the Cancer research in the UK, around 1% of breast cancers in women are caused due to the oral contraceptives. Though it protects you against various other cancers such as ovarian or any health issue related to the womb, there is still a presence of increased breast cancer risk.

Continue reading “Increased Risk of Breast Cancer Due to Contraceptive Pills” »

Nov 8, 2017

A Demonstration of Rejuvenation in Old Human Cells

Posted by in categories: biotech/medical, life extension

Today, we are going to have a look at a new study that shows that senescent, non-dividing aged cells can be somewhat restored to working order using a new technique.

Before we do that, let’s take a look at what senescent cells are and how cellular senescence protects us from cancer and other harmful diseases.

Read more

Nov 7, 2017

Transistor breakthrough brings liquid computers closer to reality

Posted by in categories: biotech/medical, robotics/AI

In a step towards creating a new class of electronics that look and feel like soft, natural organisms, mechanical engineers at Carnegie Mellon University are developing a fluidic transistor out of a metal alloy of indium and gallium that is liquid at room temperature. From biocompatible disease monitors to shape-shifting robots, the potential applications for such squishy computers are intriguing.

Until recently, the only example of liquid electronics were microswitches made up of tiny glass tubes with a bead of mercury inside that closes the switch when it rolls between two wires. Essentially, the fluidic transistor is a much more sophisticated switch that’s made of a liquid metal alloy that is non-toxic, so it can be infused into rubber to create soft, stretchable circuits.

Unlike the mercury switch, where tilting the vial closes the circuit, the fluidic transistor works by opening and closing the connection between metal droplets using the direction of the voltage. When it flows in one direction, the droplets combine and the circuit closes. If it flows the other way, the droplet splits and the circuit opens.

Continue reading “Transistor breakthrough brings liquid computers closer to reality” »

Nov 6, 2017

How to live forever: Here are the ways Silicon Valley plans to conquer death

Posted by in categories: biotech/medical, life extension, robotics/AI

Tech folks are a little antsy about the whole death thing. They’re putting money behind DNA ‘hacking,’ organ printing and tiny robots that might kill what ails you.

Read more

Nov 6, 2017

Humanoid robot market to double by 2023, industrial robotics to hit $72B

Posted by in categories: biotech/medical, food, habitats, robotics/AI

“The humanoid robot market will grow from $320.3 million this year to $3.9 billion in 2023,”

The consumer market is definitely there, but you have to deliver a robot that can do practical things. For people working on robots out there. Right Now, I would just sit and focus on a robot that can move around an average kitchen, and make the most basic of meals; show that it can be done, and be sold for a reasonable price, that would be Phase 1. Phase 2 would be rigging up the cooking robot to be able to at least clean an kitchen and a bathroom, eventually an entire house. Phase 3 would be rigging up the cooking/cleaning robot to be able to do basic landscaping tasks. At that point i believe every household in America would want one. Phase 4 would be rigging it with niche entertainment features, and rigging it with the human level AI that turns up around 2029.


Greater interest from manufacturing, medicine, and retail will drive robotics growth for the next five years.

Continue reading “Humanoid robot market to double by 2023, industrial robotics to hit $72B” »

Nov 6, 2017

Could Blood Plasma Be The Fountain Of Youth?

Posted by in categories: biotech/medical, life extension

Dr. Aubrey de Grey is in the news again, this time he appears on CBS talking about the recent interest in blood plasma as a possible way to combat age-related diseases. To find out more about the work he and the SENS Research Foundation are doing check out www.sens.org


SAN FRANCISCO (CBS SF) — Blood has always been known as “the Gift of Life” and a growing number of Bay Area researchers are currently trying to isolate a factor in blood that may turn back the hands of time.

“We don’t know how soon we’re going to defeat aging,” proclaimed Aubrey de Grey. “We should be able to keep people truly in a youthful state of health, no matter how long they live and that means the risk of death will not rise.”

Continue reading “Could Blood Plasma Be The Fountain Of Youth?” »

Nov 6, 2017

Why Bringing Aging Under Medical Control Probably Wont Create a Gerontocracy

Posted by in categories: biotech/medical, employment, life extension

One concern some people have about bringing aging under medical control is that it might create an immortal Gerontocracy controlling society.


As I discussed in another article, rejuvenation biotechnology would allow older adults to continue working and producing wealth for much longer than they can today, thus benefiting society in many ways.

However, some people are concerned that this might do more harm than good; imagine all those rejuvenated old farts holding onto their jobs forever, preventing the young from getting jobs themselves! Not to mention the risk of a gerontocratic world, where powerful older people get a touch too attached to their chairs, never allowing younger people a chance!

Read more

Nov 6, 2017

Gut Bacteria are Important in Cancer Risk

Posted by in category: biotech/medical

Changes to the microbiome in the gut may explain why related conditions are linked to different risk levels and types of gastric tumors, according to a new study.

What are the microbiota and microbiome?

The microbiota is an “ecological community of commensal, symbiotic and pathogenic microorganisms” found in and on all multicellular organisms. A microbiota includes various bacteria, archaea, protists, fungi, and viruses. The microbiota has been found to be crucial for the immunologic, hormonal and metabolic balance (homeostasis) of its host.

Read more